Insider Transactions in Q2 2022 at Amicus Therapeutics, Inc. (FOLD)
Insider Transaction List (Q2 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 21
2022
|
Ellen Rosenberg Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
11,122
-3.67%
|
$111,220
$10.0 P/Share
|
Jun 21
2022
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
16,410
-2.32%
|
$164,100
$10.0 P/Share
|
Jun 21
2022
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,410
+2.27%
|
$49,230
$3.53 P/Share
|
Jun 17
2022
|
Daphne Quimi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,396
-1.26%
|
$39,564
$9.0 P/Share
|
Jun 15
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
10,468
-1.12%
|
$83,744
$8.01 P/Share
|
Jun 09
2022
|
Lynn Dorsey Bleil |
BUY
Grant, award, or other acquisition
|
Direct |
12,671
+14.77%
|
-
|
Jun 09
2022
|
Michael Aaron Kelly |
BUY
Grant, award, or other acquisition
|
Direct |
12,671
+28.61%
|
-
|
Jun 09
2022
|
Margaret G Mcglynn |
BUY
Grant, award, or other acquisition
|
Direct |
12,671
+19.99%
|
-
|
Jun 09
2022
|
Michael Raab |
BUY
Grant, award, or other acquisition
|
Direct |
12,671
+20.41%
|
-
|
Jun 09
2022
|
Eiry Roberts |
BUY
Grant, award, or other acquisition
|
Direct |
12,671
+26.34%
|
-
|
Jun 09
2022
|
Glenn Sblendorio |
BUY
Grant, award, or other acquisition
|
Direct |
12,671
+15.01%
|
-
|
Jun 09
2022
|
Craig A Wheeler |
BUY
Grant, award, or other acquisition
|
Direct |
12,671
+22.44%
|
-
|
Jun 09
2022
|
Burke W Whitman |
BUY
Grant, award, or other acquisition
|
Direct |
12,671
+14.01%
|
-
|
Jun 03
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
11,346
-1.2%
|
$90,768
$8.0 P/Share
|
May 23
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
21,814
-2.26%
|
$174,512
$8.0 P/Share
|
May 02
2022
|
Michael Raab |
SELL
Open market or private sale
|
Direct |
15,000
-28.99%
|
$90,000
$6.99 P/Share
|
May 02
2022
|
Michael Raab |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+22.47%
|
$60,000
$4.79 P/Share
|
May 02
2022
|
Margaret G Mcglynn |
SELL
Open market or private sale
|
Direct |
15,000
-28.28%
|
$90,000
$6.99 P/Share
|
May 02
2022
|
Margaret G Mcglynn |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+22.05%
|
$60,000
$4.79 P/Share
|
Apr 19
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
8,254
-0.85%
|
$66,032
$8.01 P/Share
|
Apr 18
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,214
-0.23%
|
$17,712
$8.04 P/Share
|
Apr 07
2022
|
Ellen Rosenberg Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
11,018
-3.51%
|
$99,162
$9.06 P/Share
|